Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Corrigendum to "Postnatal nutritional deficit is an independent predictor of bronchopulmonary dysplasia among extremely premature infants born at or <28 weeks gestation" [Early Hum. Dev. 131 (2019) 29-35].

Malikiwi AI, Lee YM, Davies-Tuck M, Wong FY.

Early Hum Dev. 2019 Jul;134:13. doi: 10.1016/j.earlhumdev.2019.05.001. Epub 2019 May 15. No abstract available.

PMID:
31102929
2.

Postnatal nutritional deficit is an independent predictor of bronchopulmonary dysplasia among extremely premature infants born at or <28 weeks gestation: Some methodological issues.

Bidhendi Yarandi R, Panahi MH.

Early Hum Dev. 2019 Jul;134:47. doi: 10.1016/j.earlhumdev.2019.04.009. Epub 2019 Apr 25. No abstract available.

PMID:
31029543
3.

Postnatal nutritional deficit is an independent predictor of bronchopulmonary dysplasia among extremely premature infants born at or less than 28 weeks gestation.

Malikiwi AI, Lee YM, Davies-Tuck M, Wong FY.

Early Hum Dev. 2019 Apr;131:29-35. doi: 10.1016/j.earlhumdev.2019.02.005. Epub 2019 Feb 27. Erratum in: Early Hum Dev. 2019 Jul;134:13.

PMID:
30825742
4.

The relationship between eosinophilia and bronchopulmonary dysplasia in premature infants at less than 34 weeks' gestation.

Yang JY, Cha J, Shim SY, Cho SJ, Park EA.

Korean J Pediatr. 2014 Apr;57(4):171-7. doi: 10.3345/kjp.2014.57.4.171. Epub 2014 Apr 30.

5.

Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants.

Laughon MM, Langer JC, Bose CL, Smith PB, Ambalavanan N, Kennedy KA, Stoll BJ, Buchter S, Laptook AR, Ehrenkranz RA, Cotten CM, Wilson-Costello DE, Shankaran S, Van Meurs KP, Davis AS, Gantz MG, Finer NN, Yoder BA, Faix RG, Carlo WA, Schibler KR, Newman NS, Rich W, Das A, Higgins RD, Walsh MC; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.

Am J Respir Crit Care Med. 2011 Jun 15;183(12):1715-22. doi: 10.1164/rccm.201101-0055OC. Epub 2011 Mar 4.

6.

Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.

Baud O, Maury L, Lebail F, Ramful D, El Moussawi F, Nicaise C, Zupan-Simunek V, Coursol A, Beuchée A, Bolot P, Andrini P, Mohamed D, Alberti C; PREMILOC trial study group.

Lancet. 2016 Apr 30;387(10030):1827-36. doi: 10.1016/S0140-6736(16)00202-6. Epub 2016 Feb 23.

PMID:
26916176
7.

Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012.

Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S, Laptook AR, Sánchez PJ, Van Meurs KP, Wyckoff M, Das A, Hale EC, Ball MB, Newman NS, Schibler K, Poindexter BB, Kennedy KA, Cotten CM, Watterberg KL, D'Angio CT, DeMauro SB, Truog WE, Devaskar U, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.

JAMA. 2015 Sep 8;314(10):1039-51. doi: 10.1001/jama.2015.10244.

8.

Effects of the early administration of sivelestat sodium on bronchopulmonary dysplasia in infants: A retrospective cohort study.

Ogawa R, Mori R, Iida K, Uchida Y, Oshiro M, Kageyama M, Kato Y, Tanaka T, Nakata Y, Nishimura Y, Hokuto I, Bonno M, Matsumoto N, Ito M, Takahashi N, Namba F.

Early Hum Dev. 2017 Dec;115:71-76. doi: 10.1016/j.earlhumdev.2017.09.016. Epub 2017 Sep 23.

PMID:
28950234
9.

Natural History of Postnatal Cardiopulmonary Adaptation in Infants Born Extremely Preterm and Risk for Death or Bronchopulmonary Dysplasia.

Mirza H, Garcia JA, Crawford E, Pepe J, Zussman M, Wadhawan R, Oh W.

J Pediatr. 2018 Jul;198:187-193.e1. doi: 10.1016/j.jpeds.2018.02.034. Epub 2018 Apr 3.

PMID:
29625730
10.

Brainstem auditory abnormality in extremely premature babies and the impact of neonatal bronchopulmonary dysplasia.

Wang C, Jiang ZD.

Acta Obstet Gynecol Scand. 2018 May;97(5):545-551. doi: 10.1111/aogs.13312. Epub 2018 Feb 23.

PMID:
29381192
11.

Trends in Survival and Incidence of Bronchopulmonary Dysplasia in Extremely Preterm Infants at 23-26 Weeks Gestation.

Kim JK, Chang YS, Sung S, Ahn SY, Yoo HS, Park WS.

J Korean Med Sci. 2016 Mar;31(3):423-9. doi: 10.3346/jkms.2016.31.3.423. Epub 2016 Feb 17.

12.

Corrigendum to "Postnatal N-acetylcysteine does not provide neuroprotection in extremely low birth weight infants: A follow-up of a randomized controlled trial" [Early Hum. Dev. 132(2019) 13-17].

Kiuru A, Ahola T, Klenberg L, Tommiska V, Lano A, Kleemola P, Haavisto A, Fellman V.

Early Hum Dev. 2019 Jul;134:12. doi: 10.1016/j.earlhumdev.2019.05.004. Epub 2019 May 14. No abstract available.

PMID:
31100514
14.

Effect of chorioamnionitis on mortality, early onset neonatal sepsis and bronchopulmonary dysplasia in preterm neonates with birth weight of < 1,500 grams.

Stimac M, Juretić E, Vukelić V, Matasić NP, Kos M, Babić D.

Coll Antropol. 2014 Mar;38(1):167-71.

PMID:
24851613
15.

Ureaplasma urealyticum: no independent role in the pathogenesis of bronchopulmonary dysplasia.

Aaltonen R, Vahlberg T, Lehtonen L, Alanen A.

Acta Obstet Gynecol Scand. 2006;85(11):1354-9.

PMID:
17091417
16.

Outcomes of extremely low birth weight (<1 kg) and extremely low gestational age (<28 weeks) infants with bronchopulmonary dysplasia: effects of practice changes in 2000 to 2003.

Kobaly K, Schluchter M, Minich N, Friedman H, Taylor HG, Wilson-Costello D, Hack M.

Pediatrics. 2008 Jan;121(1):73-81. doi: 10.1542/peds.2007-1444.

PMID:
18166559
17.

Assessment of the neuropsychomotor development in the first year of life of premature infants with and without bronchopulmonary dysplasia.

Silva LV, Araújo LB, Azevedo VMGO.

Rev Bras Ter Intensiva. 2018 Apr-Jun;30(2):174-180. doi: 10.5935/0103-507X.20180023. Portuguese, English.

18.

Survival Among Infants Born at 22 or 23 Weeks' Gestation Following Active Prenatal and Postnatal Care.

Mehler K, Oberthuer A, Keller T, Becker I, Valter M, Roth B, Kribs A.

JAMA Pediatr. 2016 Jul 1;170(7):671-7. doi: 10.1001/jamapediatrics.2016.0207.

PMID:
27214875
19.

Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.

Doyle LW, Cheong JL, Ehrenkranz RA, Halliday HL.

Cochrane Database Syst Rev. 2017 Oct 24;10:CD001146. doi: 10.1002/14651858.CD001146.pub5. Review.

20.

Growth failure and altered body composition are established by one month of age in infants with bronchopulmonary dysplasia.

deRegnier RA, Guilbert TW, Mills MM, Georgieff MK.

J Nutr. 1996 Jan;126(1):168-75.

PMID:
8558298

Supplemental Content

Support Center